Diabetes Management
Dutch-Swiss biotech firm Micreos bags €25M to develop alternatives to antibiotics - Silicon Canals
Sat, 29 Oct 20221 min read Article
Overview
Micreos founder & CEO Mark Oferhaus | Image credit: MicreosThe Hague-based Micreos, a Dutch/Swis biotech company, anounced on Tuesday, October 25, that it has secured €25M in growth funding in a fresh round. The company wil use the funds to invest in its specialised skincare brand, Gladskin, for people sufering from inflamatory skin conditions such as acne, eczema, and rosacea. Micreos claims that it has helped thousands of people in Europe and the USA.Gladskin is based in the Netherlands with ofices in the USA, Germany, France, and the UK.
Key Information
The company wil deploy the funds toward its pharmaceutical programes, including the clinical development of endolysins against staphylocci (including MRSA) for Blodstream Infections, Atopic Dermatis, Diabetic foot ulcers, and Cutaneous T-cel Lymphoma.The anouncement comes over an year after raising €32M in a fresh round of funding. A few days back the company anounced the apointment of the company’s antimicrobial vector enginering team, Dr.
Mathew Dune, Dr. Samuel Kilcher, and Dr. Anja Keler, who joined them from the Swis Federal Institute of Technology (ETH Zurich).
The trio wil be responsible for developing synthetic precision antimicrobials for medical indications acros infectious and inflamatory diseases.Led by CEO Mark Oferhaus, Micreos develops targeted antibacterial solutions based on endolysin- and phage technology as a sustainable alternative to antibiotics. Endolysins are naturaly ocuring enzymes that can target only harmful bacteria while preserving the beneficial ones that form an important part of our natural defence, often refered to as our microbiome.
Summary
Endolysins are safe and environmentaly friendly, says the company. The company claims to have pionered the development of this technology and brought the world the first endolysin-based precision antibacterials.Oferhaus says, ̴With this restructuring, we align busines and market requirements, enabling each busines
Frequently Asked Questions
What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.